Derivatives of pyridoxine for inhibiting HIV integrase
US8283366B2 · kind B2 · utility
3Cited by
35References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 11, 2011 |
| Grant date | Oct 9, 2012 |
| Priority date | — |
| Expiry date | Jan 11, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of Formula I or pharmaceutically acceptable salts, solvates or formulations thereof. Compounds of Formula I inhibit HIV-integrase enzyme and are useful for preventing and treating of HIV infection, acquired immune deficiency syndrome (AIDS), AIDS-related complex (ARC), hepatitis C, and other diseases and conditions caused or mediated by HIV infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.